Cyllene Therapeutics’ experimental gene therapy EG110A has received US FDA [...]
Active Care Group has announced plans to develop a new [...]
EG 427 has released encouraging first clinical data from its [...]
Cyllene Therapeutics’ experimental gene therapy EG110A has received US FDA [...]
Active Care Group has announced plans to develop a new [...]
EG 427 has released encouraging first clinical data from its [...]